The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Year: 2022
Type: article
Abstract: The emergence of SARS-CoV-2 variants of concern (VoCs) has exacerbated the COVID-19 pandemic. End of November 2021, a new SARS-CoV-2 variant namely the omicron (B.1.1.529) emerged. Since this omicron variant is heavily mutated in the spike protein, WHO classified this variant as the 5th variant of concern (VoC). We previously demonstrated that the other SARS-CoV-2 VoCs replicate efficiently in Syrian hamsters, alike also the ancestral strains. We here wanted to explore the infectivity of the omicron variant in comparison to the ancestral D614G strain. Strikingly, in hamsters that had been infected with the omicron variant, a 3 log 10 lower viral RNA load was detected in the lungs as compared to animals infected with D614G and no infectious virus was detectable in this organ. Moreover, histopathological examination of the lungs from omicron-infecetd hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia. Further experiments are needed to determine whether the omicron VoC replicates possibly more efficiently in the upper respiratory tract of hamsters than in their lungs.
Source: Antiviral Research
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,219
Funders: Bill and Melinda Gates Foundation, European Orthodontic Society, European Commission, Fonds Wetenschappelijk Onderzoek, KU Leuven, China Scholarship Council, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme, Horizon 2020, Universitaire Ziekenhuizen Leuven, KU Leuven, Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao
Awards: G1063792340, G1641547092, G2344375386, G2594633648, G434337789, G4426081576, G5562406824, G5572312171, G5977900945, DEVELOPMENT AND USE OF RELEVANT HAMSTER AND MOUSE SARS-COV-2 INFECTION MODELS TO AID IN THE DESIGN OF THERAPEUTIC AND PROPHYLACTIC OPTIONS FOR COVID-19, G7089830201, G736147916, G7905289576, Swift COronavirus therapeutics REsponse, G8983293788
OpenAlex ID: W4226059255
